Summary
This study surveyed PKU patients and their primary caretakers to assess their current management practices, the barriers to effective management, and the potential utility of a home monitor in managing PKU. A survey instrument was mailed to caretakers of all 50 patients with PKU in Utah between the ages of 2 and 18 years in 1997 (response rate 64%). It included separate components for caretakers and patients aged 10 to 18 years. Although there was uneven compliance with recommended practices, caretakers universally recognized the negative consequences of not adhering to the low-protein diet. There was, however, disagreement regarding such consequences among the older children surveyed. The primary obstacles cited to better adherence were time constraints and stress associated with food preparation and record-keeping, and the restrictions imposed on social life. Phenylalanine test results were regarded as the principal signal for the need for dietary adjustment. Despite the facts that obstacles to dietary adherence are multifaceted and that no single intervention would therefore serve as a panacea, a large majority of respondents believed a home monitor would facilitate better management of PKU through more regular and timely feedback.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Awiszus D, Unger I (1990) Coping with PKU: results of narrative interviews with parents. Eur J Pediatr 149: S45–51.
Fisch RO, Matalon R, Weisberg S, Michals K (1997) Phenylketonuria: current dietary treatment practices in the United States and Canada. J Am Coll Nutr 16: 147–151.
Glasgow RE, Anderson RM (1999) In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed [letter; comment]. Diabetes Care 22: 2090–2092.
Koch R, Azen CG, Hurst N, Friedman EG, Fishler K (1987) The effects of diet discontinuation in children with phenylketonuria. Eur J Pediatr 146: A12–16.
Koch R, Burton B, Hoganson G, et al (2002) Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 25: 333–346.
Medical Research Council Working Party on Phenylketonuria (1993a) Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. BMJ 306: 115–119.
Medical Research Council Working Party on Phenylketonuria (1993b) Recommendations on the dietary management of phenylketonuria. Arch Dis Child 68: 426–427.
NIH Consensus Development Panel (2001) National Institutes of Health consensus development conference statement. Phenylketonuria: screening and management, October 16–18, 2000. Pediatrics 108: 972–982.
Peterson K, Slover R, Gass S, Seltzer WK, McCabe LL, McCabe ER (1988) Blood phenylalanine estimation for the patient with phenylketonuria using a portable device. Biochem Med Metab Biol 39: 98–104.
Pietz J, Benninger C, Schmidt H, Scheffner D, Bickel H (1988) Long-term development of intelligence (IQ) and EEG in 34 children with phenylketonuria treated early. Eur J Pediatr 147: 361–367.
Prince AP, McMurray MP, Buist NR (1997) Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials. J Inherit Metab Dis 20: 486–498.
Ris MD, Williams SE, Hunt MM, Berry HK, Leslie N (1994) Early-treated phenylketonuria: adult neuropsychologic outcome. J Pediatr 124: 388–392.
Rylance G (1989) Outcome of early detected and early treated phenylketonuria patients. Postgrad Med J 65: S7–9.
Seashore MR, Wappner R, Cho S, de la Cruz F (1999) Development of guidelines for treatment of children with phenylketonuria: report of a meeting at the National Institute of Child Health and Human Development held August 15, 1995, National Institutes of Health, Bethesda, Maryland. Pediatrics 104: e67.
Shulman S, Fisch RO, Zempel CE, Gadish O, Chang PN (1991) Children with phenylketonuria: the interface of family and child functioning. J Dev Behav Pediatr 12: 315–321.
Smith I, Beasley MG, Wollf OH, Ades AE (1988) Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register. J Pediatr 112: 403–408.
Waitzman NJ, Bilginsoy C, Leonard CO, Ernst S, Prince A (2004) The effect of phenylalanine test frequency on management of phenylketonuria (PKU). University of Utah.
Wappner R, Cho S, Kronmal RA, Schuett V, Seashore MR (1999) Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors. Pediatrics 104: e68.
Weglage J, Funders B, Wilken B, et al (1992) Psychological and social findings in adolescents with phenylketonuria. Eur J Pediatr 151: 522–525.
Wendel U, Langenbeck (1996) Towards self-monitoring and self-treatment in phenylketonuria—way to better diet compliance. Eur J Pediatr 155: S105–107.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bilginsoy, C., Waitzman, N., Leonard, C.O. et al. Living with phenylketonuria: Perspectives of patients and their families. J Inherit Metab Dis 28, 639–649 (2005). https://doi.org/10.1007/s10545-005-4478-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10545-005-4478-8